Skip to Main Content
Back to search results

Dr. Carrie Ho is a hematologist-oncologist who focuses on blood cancers, including Hodgkin's and non-Hodgkin's lymphomas and chronic lymphocytic leukemia. She has expertise in advanced therapies, such as stem cell transplantation and CAR T-cell therapy (in which the patient's T cells are genetically modified to target cancer cells).

In her research, Ho leads clinical trials – studies that evaluate experimental treatments using human volunteers – that evaluate new targeted therapies and immunotherapy for patients with lymphoma. She also studies how these treatments impact patients' quality of life. Her goal is to find better, more effective treatment options with fewer side effects, and to ensure that patients feel supported throughout their cancer journey.

Ho earned her medical degree at the Ohio State University College of Medicine. She completed a residency in internal medicine at the Hospital of the University of Pennsylvania and a fellowship in hematology-oncology at the University of Washington, training at Fred Hutchinson Cancer Center.

  • Board Certifications

    American Board of Internal Medicine, Hematology, 2024

    American Board of Internal Medicine, Medical Oncology, 2024

    American Board of Internal Medicine, Internal Medicine, 2020

  • Fellowships

    University of Washington School of Medicine, Medical Oncology & Hematology, 2024

  • Residencies

    Hospital of the University of Pennsylvania IM GME, Internal Medicine, 2020

  • Education

    The Ohio State University College of Medicine, 2017

  • Languages

    English

Share